Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping

Journal of Clinical Microbiology

Volumn 53, Issue 5, 2015, Pages 1754-1757

  Liu, Chen Hua ^a,b   Liang, Cheng Chao ^c   Liu, Chun Jen ^a,b   Lin, Chih Lin ^d   Su, Tung Hung ^a,b   Yang, Hung Chih ^a,b   Chen, Pei Jer ^a,b   Chen, Ding Shinn ^a,e   Kao, Jia Horng ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d Taipei Municipal Hospital   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5B;

5' UNTRANSLATED REGION; ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENOTYPING TECHNIQUE; HEPATITIS B; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 6; HEPATITIS C VIRUS SUBTYPE 1A; HEPATITIS C VIRUS SUBTYPE 1B; HUMAN; HYBRIDIZATION; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LINE PROBE ASSAY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; NS5B GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE HYBRIDIZATION; CLASSIFICATION; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; HEPACIVIRUS; HEPATITIS C; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR DIAGNOSIS; PROCEDURES; VIROLOGY; YOUNG ADULT;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1;

ADULT; AGED; FEMALE; GENOTYPING TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84984535303     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03548-14     Document Type: Article

References (13)

1. Le Pogam S, Dubois F, Christen R, Raby C, Cavicchini A, Goudeau A. 1998. Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping. J Clin Microbiol 36:1461-1463.
2. Verbeeck J, Stanley MJ, Shieh J, Celis L, Huyck E, Wollants E, Morimoto J, Farrior A, Sablon E, Jankowski-Hennig M, Schaper C, Johnson P, Van Ranst M, Van Brussel M. 2008. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0. J Clin Microbiol 46:1901-1906. http://dx.doi.org/10.1128/JCM.02390-07.
3. Chen Z, Weck KE. 2002. Hepatitis C virus genotyping: interrogation of the 5= untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol 40:3127-3134. http://dx.doi.org/10.1128/JCM.40.9 .3127-3134.2002.
4. Cantaloube JF, Laperche S, Gallian P, Bouchardeau F, de Lamballerie X, de Micco P. 2006. Analysis of the 5= noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol 44:2051-2056. http://dx.doi.org/10.1128/JCM .02463-05.
5. Bouchardeau F, Cantaloube JF, Chevaliez S, Portal C, Razer A, Lefrère JJ, Pawlotsky JM, De Micco P, Laperche S. 2007. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol 45:1140-1145. http://dx.doi .org/10.1128/JCM.01982-06.
6. Ciotti M, Marcuccilli F, Guenci T, Babakir-Mina M, Chiodo F, Favarato M, Perno CF. 2010. A multicenter evaluation of the Abbott RealTime HCV Genotype II assay. J Virol Methods 167:205-207. http://dx.doi.org/10.1016/j.jviromet.2010.03.017.
7. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. 2009. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One 4:e8209. http://dx.doi.org/10.1371/journal.pone.0008209.
8. Cook L, Sullivan K, Krantz EM, Bagabag A, Jerome KR. 2006. Multiplex real-time reverse transcription-PCR assay for determination of hepatitisC virus genotypes. J Clin Microbiol 44:4149-4156. http://dx.doi.org/10 .1128/JCM.01230-06.
9. Chinchai T, Labout J, Noppornpanth S, Theamboonlers A, Haagmans BL, Osterhaus AD, Poovorawan Y. 2003. Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods 109:195-201. http://dx.doi.org/10.1016/S0166-0934(03)00071-5.
10. Germer JJ, Rys PN, Thorvilson JN, Persing DH. 1999. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol 37:2625-2630.
11. Benedet M, Adachi D, Wong A, Wong S, Pabbaraju K, Tellier R, Tang JW. 2014. The need for a sequencing-based assay to supplement the Abbott m2000 RealTime HCV Genotype II assay: a 1 year analysis. J Clin Virol 60:301-304. http://dx.doi.org/10.1016/j.jcv.2014.04.005.
12. Abbott Molecular Inc. 2013. Abbott RealTime HCVGenotype II package insert. Abbott Molecular Inc., Des Plaines, IL. http://www.accessdata.fda .gov/cdrh-docs/pdf12/P120012c.pdf.
13. Mallory MA, Lucic DX, Sears MT, Cloherty GA, Hillyard DR. 2014. Evaluation of the Abbott RealTime HCV genotype II RUO (GT II) assay with reference to 5= UTR, core and NS5B sequencing. J Clin Virol 60:22-26. http://dx.doi.org/10.1016/j.jcv.2014.02.006.